What is the Medicare GLP-1 Bridge?
It's the first time Medicare has covered GLP-1 medications for weight loss — a short-term CMS program running July 1, 2026 through December 31, 2027 that covers brand-name Wegovy, Zepbound (KwikPen), and Foundayo for a low fixed copay, for people who meet published criteria.
Why "Bridge"?
Medicare law has long excluded weight-loss drugs from Part D coverage. Rather than wait for that to change, CMS built a temporary program that runs alongside Part D — a bridge between the old rule and whatever comes next. It uses its own central processor for prior authorizations and pharmacy claims, which is why prescriptions need special routing instructions (and why doctors who haven't seen the program yet appreciate a heads-up).
Who it's designed for
Adults 18 and older with Medicare drug coverage who want a GLP-1 specifically for weight reduction or maintenance, and who met one of three BMI pathways when starting therapy: BMI 35+, BMI 30+ with certain conditions, or BMI 27+ with certain risk conditions. The full breakdown is on our criteria page.
Notably, people who've been paying out of pocket — through LillyDirect, NovoCare, or compounding pharmacies — are squarely in the program's intended audience. Self-pay history doesn't disqualify you; only receiving a GLP-1 through your Part D plan routes you elsewhere.
What it isn't
It's not a coupon, not an enrollment site, and not automatic. Your own clinician decides whether a GLP-1 is medically appropriate, writes the prescription with the program's routing instructions, and completes a prior authorization. The whole process runs through your doctor — which is why preparation is the single most useful thing you can do.
The smart way to prepare
Three things speed everything up: know how your answers compare to the published criteria before your visit, have your documentation gathered (BMI history, diagnoses, coverage card), and bring your doctor the program's prescribing steps, since the program is new to most clinics. Our free screener handles the first part and generates a doctor message; the full packet adds the clinician reference sheet.
Frequently asked questions
When does the Bridge start?
July 1, 2026. CMS describes it as running through December 31, 2027.
Which drugs are covered?
Wegovy (injection and tablets), Zepbound (KwikPen only — not vials or single-dose pens), and Foundayo (tablets), for weight reduction and maintenance. Only 28- or 30-day fills.
Is this an official Medicare site?
No. GLP1BridgeHelp.com is independent and not affiliated with CMS, Medicare, HHS, drug manufacturers, or Part D plans.
Does the Bridge replace my doctor?
No. Your clinician decides whether treatment is medically appropriate and handles the prescription and prior authorization.
Sources and review status: Content reviewed June 12, 2026, based on published CMS materials including the prescriber fact sheet (CMS Product No. 12235). Check current CMS materials: CMS Bridge overview, beneficiary information, provider information.